INmune Bio Inc.
INMB
$2.17
$0.094.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.41M | 21.36M | 24.75M | 27.73M | 33.37M |
| Total Receivables | 4.77M | 770.00K | 4.54M | 2.46M | 2.16M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 621.00K | 694.00K | 595.00K | 472.00K | 505.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.80M | 22.82M | 29.89M | 30.67M | 36.03M |
|
|
|||||
| Total Current Assets | 23.80M | 22.82M | 29.89M | 30.67M | 36.03M |
| Net Property, Plant & Equipment | 2.51M | 2.31M | 1.87M | 1.94M | 1.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 537.00K | 683.00K | 595.00K | 746.00K | 570.00K |
| Total Assets | 26.85M | 25.82M | 32.35M | 33.36M | 37.68M |
|
|
|||||
| Total Accounts Payable | 5.05M | 4.66M | 7.77M | 6.88M | 7.67M |
| Total Accrued Expenses | 25.00K | 25.00K | 25.00K | 25.00K | 184.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 812.00K | 704.00K | 623.00K | 457.00K | 220.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 511.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 511.00K |
| Total Current Liabilities | 5.89M | 5.39M | 8.42M | 7.36M | 8.59M |
|
|
|||||
| Total Current Liabilities | 5.89M | 5.39M | 8.42M | 7.36M | 8.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 593.00K | 806.00K | 411.00K | 623.00K | 231.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.48M | 6.19M | 8.83M | 7.98M | 8.82M |
|
|
|||||
| Common Stock & APIC | 237.72M | 234.80M | 233.30M | 229.92M | 226.93M |
| Retained Earnings | -215.72M | -214.44M | -209.04M | -203.77M | -197.30M |
| Treasury Stock & Other | -1.64M | -727.00K | -737.00K | -764.00K | -763.00K |
| Total Common Equity | 20.36M | 19.62M | 23.52M | 25.38M | 28.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.36M | 19.62M | 23.52M | 25.38M | 28.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.36M | 19.62M | 23.52M | 25.38M | 28.87M |
|
|
|||||